Currently a group of researchers in the US have teamed up to analyze the various aspects of vaping in order to determine the possible health effects these devices may potentially pose. The researchers have been divided up into three teams, each evaluating different areas of the e-cigarette industry. The first group of researchers has been assigned to count the number of puffs taken by numerous volunteer vapers. The second team will be scouring Facebook for an assortment of posts regarding e-cigarette modifications and people altering their devices in order to receive more nicotine. The third group of researchers built a “virtual convenience store” targeted at 13-17 year-olds, to calculate how much influence e-cigarette displays and promotions have on minors purchasing these new devices. Although the exact results from these observations are not projected to be released until 2018, the FDA has an additional 45 research projects and observations currently being conducted, totaling $270 million in e-cigarette research.

Additional questions remain before e-cigarettes are acknowledged by the FDA as a safe and acceptable alternative for cigarettes. Arguments over which chemical compounds and toxins are produced in the vapor of e-cigarettes are continually being fought. "We want to know what's in the emissions, not just the ingredients," stated Robert Balster, a toxicologist overseeing four FDA-funded projects. Flavored e-liquids have also been under attack by anti-vapor advocates, who believe these e-liquids supposedly attract children and non-smokers to e-cigarettes.

Bryan Haynes, an attorney who represents e-cigarette manufacturers responded to the upcoming FDA regulations by saying, “There shouldn’t be regulations akin to those for cigarettes without evidence of similar health impact, especially since preliminary evidence is positive for the industry”. Even individuals in the e-cigarette industry are begging the FDA to wait for the research to conclude before making any regulations or restrictions in fear of losing their businesses due to unfounded misconceptions and fears.

Just as Michael Eriksen, (dean of the School of Public Health) said, "This is the kind of research that is going to be informing the FDA's regulatory process". Lets all hope the results are honest, unbiased, and beneficial to the public and not just the governmental organizations.

Full Article Available At: